Levetiracetam Accord (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A, which modulates neurotransmitter release. By stabilizing synaptic transmission, it lowers neuronal excitability and prevents the rapid, uncontrolled firing that leads to seizures.

The specific dose of Levetiracetam Accord is determined by the prescribing clinician based on the patient’s age, weight, seizure type, and renal function. Dosage adjustments are individualized and should follow the prescriber’s instructions.

Levetiracetam is classified as Pregnancy Category B, indicating no evidence of fetal risk in animal studies but limited human data. It may be used during pregnancy only if the potential benefit justifies the risk. Breastfeeding is generally considered compatible, but a healthcare professional should evaluate each case.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levetiracetam offers a distinct mechanism by targeting SV2A, which differs from sodium‑channel blockers like carbamazepine or GABA‑enhancers such as valproate. It generally has fewer drug‑enzyme interactions, a favorable tolerability profile, and can be used as adjunctive or monotherapy in many seizure types.

Store Levetiracetam Accord at ambient temperature, below 25 °C. Keep the tablets in the original packaging, protect them from moisture, heat and direct sunlight to maintain potency throughout the shelf life.

Levetiracetam Accord is taken orally, usually with or without food, as directed by the prescriber. Tablets should be swallowed whole with water and not chewed or crushed unless specifically instructed.

Serious adverse reactions can include severe allergic responses (rash, swelling, breathing difficulty), mood disturbances such as depression or suicidal thoughts, and rare hematologic or hepatic abnormalities. Patients should seek immediate medical attention if any of these occur.

Levetiracetam Accord is contraindicated in individuals with known hypersensitivity to levetiracetam or any of its excipients. Caution is advised for patients with severe renal impairment, uncontrolled psychiatric conditions, or those taking interacting medications without proper monitoring.